In a prior study, IL-17 triggered the PD-1 pathway in cancer cells creating an immunosuppressive microenvironment (Wang et al., 2017) dominated by Treg cells whereas CD4 and Cd8 cells were inhibited (Ma et al., 2017). The gene discussed is PDCD1; the disease is cancer.